Also previously reported, there was no benefit for extended pelvic lymphadenectomy in the overall cohort for metastasis free ...

Real-world effectiveness and safety of trifluridine-tipiracil (FTD/TPI) and bevacizumab (BEV) in refractory metastatic colorectal cancer (mCRC): The BeTAS trial. This is an ASCO Meeting Abstract from ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...

Results from the PHENIX-I trial support skipping pelvic lymphadenectomy in women with early cervical cancer who have a negative sentinel lymph node biopsy. Omitting pelvic lymphadenectomy in these ...

No benefit was found in low-risk patients who underwent pelvic lymph node dissection (PLND). The extent of pelvic lymph node dissection (PLND) in patients undergoing radical prostatectomy (RP) for ...

Pelvic lymph node metastases visualized on PSMA PET/CT prior to prostate cancer surgery independently predicts an increased risk for biochemical disease progression, a study found. Patients with ...

Preoperative (left; top and bottom) and postoperative PSMA-PET/CT images (right; top and bottom) demonstrate the successful removal of two positive pelvic lymph nodes in the radioguided surgical ...

Clinical Interchangeability of PD-L1 Immunohistochemistry Assays in First-Line Non–Small Cell Lung Cancer Management With Cemiplimab Internal iliac and obturator lymph nodes are common sites of ...

Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limited ...